New clinical trial offers hope for patients with rare immune disease IgG4-RD

A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4-RD)

Twist Bioscience lays off 212 staffers, mostly in San Francisco

Twist Bioscience is laying off 212 employees, effective July 3, according to California WARN notices — with 197 of those staffers in San Francisco. The

June 17, 2023

Neural circuitry in the spinal cord allows brain-independent motor learning

Aya Takeoka at the RIKEN Center for Brain Science (CBS) in Japan and colleagues have discovered the neural circuitry in the spinal cord that allows

April 13, 2024

October births linked to higher flu vaccination and lower diagnosis rates

Children born in October are both more likely to be vaccinated against influenza and least likely to be diagnosed with influenza compared with children born

February 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.